Friday, November 6, 2026

ESCO Technologies Inc. And 3 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

December 31, 2020

ESCO Technologies Inc. And 3 Other Stocks Have Very High Payout Ratio

We have gathered information concerning stocks with the highest payout ratio up to now. The payout ratio in itself isn't a assurance of good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.

1. Territorial Bancorp Inc.

47.18% Payout Ratio

Territorial Bancorp Inc. operates as the holding company for Territorial Savings Bank that provides various financial services to individuals, families, and businesses in the State of Hawaii.

As maintained by Morningstar, Inc., the next dividend payment is on Nov 9, 2020, the estimated forward annual dividend rate is 0.92 and the estimated forward annual dividend yield is 3.86%.

Territorial Bancorp Inc.'s sales growth this year is anticipated to be 2.6% and a negative 0.6% for next year.

Year-on-year quarterly revenue growth declined by 7.2%, now sitting on 61.3M for the twelve trailing months.

Territorial Bancorp Inc.'s sales growth is 2.3% for the ongoing present quarter and 2.7% for the next. The company's growth estimates for the current quarter and the next is negative 20.4% and negative -8.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.36%.

Volatility

Territorial Bancorp Inc.'s last day, last week, and last month's average volatility was a positive 0.67%, a negative 0.30%, and a positive 0.46%, respectively.

Territorial Bancorp Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.07%, 2.04%, and 2.96%, respectively.

Territorial Bancorp Inc.'s Stock Yearly Top and Bottom Value

Territorial Bancorp Inc.'s stock is valued at $23.99 at 13:23 EST, way under its 52-week high of $31.57 and way higher than its 52-week low of $19.23.

Territorial Bancorp Inc.'s Moving Average

Territorial Bancorp Inc.'s value is above its 50-day moving average of $23.00 and higher than its 200-day moving average of $22.20.

2. Pioneer Municipal High Income Advantage Trust

79.92% Payout Ratio

Pioneer Municipal High Income Advantage Trust is a closed ended fixed income mutual fund launched and managed by Pioneer Investment Management, Inc. The fund invests in the fixed income markets of the United States.

As stated by Morningstar, Inc., the next dividend payment is on Dec 9, 2020, the estimated forward annual dividend rate is 0.63 and the estimated forward annual dividend yield is 5.42%.

Pioneer Municipal High Income Advantage Trust's sales growth this year is anticipated to be negative 0% and a negative 0% for next year.

Year-on-year quarterly revenue growth declined by 8.2%, now sitting on 18.43M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.32%.

Volatility

Pioneer Municipal High Income Advantage Trust's last day, last week, and last month's average volatility was 0.43%, 0.28%, and 0.07%, respectively.

Pioneer Municipal High Income Advantage Trust's last day, last week, and last month's high and low average amplitude percentage was 0.87%, 1.22%, and 0.83%, respectively.

Pioneer Municipal High Income Advantage Trust's Stock Yearly Top and Bottom Value

Pioneer Municipal High Income Advantage Trust's stock is valued at $11.62 at 13:23 EST, below its 52-week high of $11.75 and way higher than its 52-week low of $7.61.

Pioneer Municipal High Income Advantage Trust's Moving Average

Pioneer Municipal High Income Advantage Trust's value is higher than its 50-day moving average of $11.50 and higher than its 200-day moving average of $11.09.

3. Hanover Insurance Group Inc

33.04% Payout Ratio

The Hanover Insurance Group, Inc., through its subsidiaries, provides various property and casualty insurance products and services in the United States.

As stated by Morningstar, Inc., the next dividend payment is on Dec 16, 2020, the estimated forward annual dividend rate is 2.8 and the estimated forward annual dividend yield is 2.42%.

Hanover Insurance Group Inc's sales growth this year is anticipated to be 0.6% and 4.4% for next year.

Year-on-year quarterly revenue growth grew by 2.9%, now sitting on 4.79B for the twelve trailing months.

Hanover Insurance Group Inc's sales growth is 1.9% for the present current quarter and 3% for the next. The company's growth estimates for the current quarter and the next is 13.4% and 9.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.81%.

Volatility

Hanover Insurance Group Inc's last day, last week, and last month's average volatility was 0.38%, 0.18%, and 0.16%, respectively.

Hanover Insurance Group Inc's last day, last week, and last month's high and low average amplitude percentage was 1.34%, 1.40%, and 1.83%, respectively.

Hanover Insurance Group Inc's Stock Yearly Top and Bottom Value

Hanover Insurance Group Inc's stock is valued at $115.62 at 13:23 EST, way under its 52-week high of $144.71 and way higher than its 52-week low of $75.11.

Hanover Insurance Group Inc's Moving Average

Hanover Insurance Group Inc's value is higher than its 50-day moving average of $115.61 and way higher than its 200-day moving average of $103.24.

4. ESCO Technologies Inc.

32.99% Payout Ratio

ESCO Technologies Inc. produces and supplies engineered products and systems for utility, industrial, aerospace, and commercial users worldwide.

As maintained by Morningstar, Inc., the next dividend payment is on Dec 30, 2020, the estimated forward annual dividend rate is 0.32 and the estimated forward annual dividend yield is 0.32%.

ESCO Technologies Inc.'s sales growth this year is anticipated to be 5.4% and 8.1% for next year.

Year-on-year quarterly revenue growth declined by 2.4%, now sitting on 732.92M for the twelve trailing months.

ESCO Technologies Inc.'s sales growth for the next quarter is 2.8%. The company's growth estimates for the current quarter and the next is 20.9% and 2.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.85%.

Volatility

ESCO Technologies Inc.'s last day, last week, and last month's average volatility was 1.88%, 0.64%, and 0.15%, respectively.

ESCO Technologies Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.02%, 1.87%, and 2.31%, respectively.

ESCO Technologies Inc.'s Stock Yearly Top and Bottom Value

ESCO Technologies Inc.'s stock is valued at $102.11 at 13:23 EST, under its 52-week high of $107.10 and way above its 52-week low of $62.64.

ESCO Technologies Inc.'s Moving Average

ESCO Technologies Inc.'s value is above its 50-day moving average of $100.00 and way above its 200-day moving average of $89.16.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com